Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rho‑kinase inhibitors after cataract surgery in diabetic patients
TCTR20250910003Phase 4Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 4 trial in corneal endothelial dysfunction, cataract and type 2 diabetes mellitus (T2DM), sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start Oct 2025; status: not yet recruiting.
02
Conditions
corneal endothelial dysfunctioncataracttype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20250910003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250910003.